Commentary by Helen Kourlas, PharmD and John Papadopoulas, PharmD, Pharmacology Section Editors
The sulfonylureas are members of a class of substituted arylsulfonylureas that have been used clinically since the 1950s. These agents are usually divided into two categories or generations. First generation agents include acetohexamide, chlorpropamide, tolazamide, and tolbutamide (the …
Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
Moving through the journals this week, it is all about primary care.
There was an interesting article for Primary Care MDs in this week’s …
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical CenterÂ
Welcome to Case 4 of our special diabetes series intended to highlight the essentials …
Case presentation by Elizabeth Ross MD, Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the links below to review the case and the radiological findings. …
Commentary by Josh Olstein MD, Associate Editor, Clinical Correlations
As a future gastroenterologist, I was drawn to a study in the October 4th edition of the New England Journal of Medicine that …
Commentary by Daniel Frenkel, PGY-2
Case: A 46 year old male with diabetes on oral hypoglycemic medications is admitted to the hospital with one day of constant epigastric pain, nausea, vomiting, and an inability to tolerate oral intake. You …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
Diabetic neuropathy is one of the most commonly encountered complications of diabetes mellitus. It is seen in up …
Commentary by Danise Schiliro-Chuang MD, NYU Chief Resident
Let’s start on the theme of cardiovascular disease risk reduction, a topic making headlines this week. A September 28 New York Times article previews the …